Abstract
Objective This systematic review and meta-analysis aimed to quantitatively evaluate the effect of the COVID-19 pandemic on respiratory syncytial virus (RSV) associated bronchiolitis among hospitalised infants.
Methods The study protocol was registered in the PROSPERO database (CRD42022314000) and was designed based on PRISMA guidelines updated in May 2020. The meta-analysis component was modified appropriately to synthesise the pooled proportion of infants having RSV- associated bronchiolitis before the COVID-19 pandemic in 2019 and during the pandemic with 95% confidence interval (CI).
Results The eight qualified studies for the meta-analysis were from Spain, Italy, France and China, including 109,186 symptomatic cases of bronchiolitis before the pandemic in 2019 and 61,982 cases in 2020-2021. The quantitative analysis included laboratory-confirmed RSV infection in 7691 infants with bronchiolitis reported before the pandemic in 2019. Meanwhile, during the pandemic, 4964 cases were associated with RSV infection. The pooled proportion of RSV-associated bronchiolitis cases before the pandemic in 2019 was 16.74% (95% CI 11.73-22.43%). The pooled proportion of confirmed RSV cases during the pandemic in 2020/2021 was 19.20 % (95% CI 12.01-27.59%).
Conclusion There was an increase in RSV activity after the relaxation of stringent public health measures during the COVID-19 pandemic.
• What is already known on this topic The epidemiology of RSV infection which accounts for most bronchiolitis and viral pneumonias in infants was changed during the COVID-19 pandemic. During the spring or summer seasons, a resurgence in RSV positivity among bronchiolitis cases was noted globally during the COVID-19 pandemic.
• What this study adds In spite of reporting lower number of bronchiolitis cases, more number of RSV associated bronchiolitis cases were detected among infants during the COVID-19 pandemic. Meanwhile, countries perceiving a very low number of RSV cases are at an increased risk of resurgence of RSV activity, mainly among older RSV-naïve children.
• How this study might affect research, practice or policy Monitoring the effect of COVID-19 on RSV activity in infants is essential and regular sentinel surveillance of RSV must be carried out along with influenza and SARS-CoV-2 viruses to minimise the burden of hospitalisation and mortality. Health care professionals and hospitals must be prepared to tackle the rising number of paediatric RSV cases throughout the year. This review also emphasises the importance of promoting RSV maternal vaccines and passive childhood immunisation with monoclonal antibodies (mAbs).
• Policy implications Policy makers from low-income countries have to ensure regular surveillance of RSV-associated bronchiolitis as these regions report the highest number of morbidity and mortality among infants. Even during challenging times of the pandemics and epidemics, monitoring has to be sustained.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Policy implications was added in the Page 2 after the abstract. Policymakers from low-income countries have to ensure regular surveillance of RSV-associated bronchiolitis as these regions report the highest number of morbidity and mortality among infants. Even during challenging times of the pandemics and epidemics, monitoring has to be sustained.
Data Availability
All data produced in the present study are available upon reasonable request to the corresponding author.
https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42022314000
